Cargando…
Evaluation of the Possible Utilization of (68)Ga-DOTATOC in Diagnosis of Adenocarcinoma Breast Cancer
OBJECTIVE(S): Studies have indicated advantageous properties of [DOTA-DPhe(1), Tyr(3)] octreotide (DOTATOC) in tumor models and labeling with gallium. Breast cancer is the second leading cause of cancer mortality in women, and most of these cancers are often an adenocarcinoma. Due to the importance...
Autores principales: | Zolghadri, Samaneh, Naderi, Mojdeh, Yousefnia, Hassan, Alirezapour, Behrouz, Beiki, Davood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia Oceania Journal of Nuclear Medicine & Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765332/ https://www.ncbi.nlm.nih.gov/pubmed/29333466 http://dx.doi.org/10.22038/aojnmb.2017.23695.1168 |
Ejemplares similares
-
Preclinical Study of (68)Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs
por: Naderi, Mojdeh, et al.
Publicado: (2016) -
Human Absorbed Dose Estimation of (111)In-DOTA-PR81 as a Novel High Potential Agent for Breast Cancer Imaging
por: Yousefnia, Hassan, et al.
Publicado: (2022) -
Human Dose Assessment of (68)Ga-NODAGA-RGD-BBN Heterodimer Peptide based on Animal Data
por: Amraee, Naeimeh, et al.
Publicado: (2022) -
Development and evaluation of (89)Zr-trastuzumab for clinical applications
por: Mohammadpour-Ghazi, Fatemeh, et al.
Publicado: (2023) -
Meningiomas: A Comparative Study of (68)Ga-DOTATOC, (68)Ga-DOTANOC and (68)Ga-DOTATATE for Molecular Imaging in Mice
por: Soto-Montenegro, María Luisa, et al.
Publicado: (2014)